Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.320
-0.100 (-7.04%)
At close: Dec 5, 2025, 4:00 PM EST
1.370
+0.050 (3.79%)
After-hours: Dec 5, 2025, 7:57 PM EST
Marker Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 22 | 33 | 49 | 23 | 79 | 70 | |
| Market Cap Growth | -15.68% | -31.89% | 115.29% | -71.23% | 13.36% | -47.12% | |
| Enterprise Value | 4 | 24 | 31 | 12 | 42 | 55 | |
| Last Close Price | 1.32 | 3.11 | 5.50 | 2.66 | 9.50 | 14.50 | |
| PS Ratio | 3.59 | 5.05 | 14.77 | 6.46 | 63.58 | 149.18 | |
| PB Ratio | 1.20 | 1.79 | 3.48 | 1.16 | 1.80 | 2.55 | |
| P/TBV Ratio | 1.20 | 1.79 | 3.48 | 1.16 | 1.80 | 2.55 | |
| EV/Sales Ratio | 0.94 | 3.69 | 9.49 | 3.52 | 34.02 | 117.63 | |
| Debt / Equity Ratio | - | - | - | - | 0.27 | 0.45 | |
| Asset Turnover | 0.29 | 0.34 | 0.13 | 0.07 | 0.02 | 0.01 | |
| Quick Ratio | 5.76 | 6.22 | 5.25 | 1.82 | 3.28 | 3.49 | |
| Current Ratio | 6.50 | 6.36 | 5.57 | 2.14 | 3.56 | 3.81 | |
| Return on Equity (ROE) | -110.67% | -65.81% | -83.47% | -62.20% | -117.42% | -80.37% | |
| Return on Assets (ROA) | -55.20% | -35.50% | -35.36% | -24.12% | -43.38% | -39.26% | |
| Return on Capital (ROIC) | -69.73% | -42.62% | -54.16% | -32.79% | -51.70% | -42.90% | |
| Return on Capital Employed (ROCE) | -78.40% | -59.90% | -103.80% | -74.30% | -71.50% | -73.70% | |
| Earnings Yield | -64.97% | -32.23% | -16.85% | -131.80% | -53.05% | -41.22% | |
| FCF Yield | -67.32% | -32.76% | -33.63% | -118.78% | -38.52% | -42.06% | |
| Buyback Yield / Dilution | -43.29% | -1.94% | -5.49% | -9.16% | -62.64% | -3.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.